Timos Papagatsias: Interested in Social Media in the Hematology Space?
Timos Papagatsias, CEO of LucidQuest, shared on LinkedIn:
”Interested in social media in the Hematology space?
Download our ASH24 social media report!
Our team monitored and analyzed ASH-related posts on X (previously Twitter) before, during, and after the event. Here are some key takeaways:
Key Hashtags: mmsm led the discussion, emphasizing Multiple Myeloma, followed by lymsm and leusm. Hashtags like Med Twitter, mpnsm, Moffitt ASH24, MedEd, and Blood Journals also garnered significant traction, reflecting a broad and dynamic conversation around hematological research and treatment.
Top Discussion Themes: Data was the primary focus (~17.7%), highlighting the importance of evidence-based insights.
Efficacy followed closely (~16.2%), with Clinical Trials at ~13.7%. Additional themes around Treatments, patient perspectives, and Safety highlighted the drive towards more effective and patient-centered care.
Leading Voices: Doctors dominated the conversation (~56%), with Education-related and Media accounts contributing ~8% and ~10% respectively.
Research (~12%), Company (~2%), and Advocate (~10%) accounts were also active, while Nurses again scored low (~2%) in high-volume posts.
Audience Sentiment: The sentiment was overwhelmingly positive (~85%), celebrating the event’s educational value and novel insights.
About 10% were neutral, offering real-time updates and general information, while ~5% expressed negative feedback, primarily regarding session overcrowding and issues with the conference app.
Text Analytics: Discussions centered on patient-centric, data-driven approaches in Multiple Myeloma and Lymphoma management.
Treatments like CART therapy and Daratumumab attracted considerable attention, reflecting the growing impact of advanced therapeutics in hematology.
If you’re interested in social media coverage during conferences, send us a message at [email protected]; we cover multiple therapyareas and events!”
Stay updated with Hemostasis Today.
-
Jul 28, 2026, 02:54Joseph R. Shaw: Why Stroke Occurs Despite Anticoagulation
-
Jul 28, 2026, 02:45Are VWD Clinical Trials Missing What Matters Most to Women? – RPTH
-
Jul 28, 2026, 02:38Umberto Pensato: New BMJ Review on Breakthrough Stroke in Patients Receiving DOACs Is Now Live
-
Jul 27, 2026, 17:29Muhammad Numan: Normal MCV Does Not Exclude B12 Deficiency
-
Jul 27, 2026, 17:15ISTH 2026 Congress Paris Opens with a Powerful Message: Science Beyond Border
-
Jul 27, 2026, 17:14Michael Ombrello։ Decoding How Autoantibodies Cause Disease
-
Jul 27, 2026, 16:57Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
-
Jul 27, 2026, 16:53Arun V. J.: How to Find a Mentor When You Know No One
-
Jul 27, 2026, 16:45Urtė Cholinaitė: A Meaningful Experience at the Lithuania Hemophilia Society Summer Camp